Skip to content

DOKTER BAMBYNEK: what changed

BE 0473.633.677NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€163,420
2024 · €161,192+€2,228
Equity
€741,532
2024 · €651,112+€90,420
Cash
€96,263
2024 · €641,839-€545,576
Balance sheet total
€824,333
2024 · €773,930+€50,403

Largest movements

2024 to 2025
Assets
  • Current investments +€596,560

    up €596,560 (+1,449%), from €41,175 to €637,735

  • Cash -€545,576

    down €545,576 (-85.0%), from €641,839 to €96,263

    mainly Current investments (-€596,560) and Contributions, distributions and other (-€73,000)

Equity and liabilities
  • Reserves +€89,000

    up €89,000 (+14.0%), from €633,860 to €722,860

  • Other debts -€21,926

    down €21,926 (-23.1%), from €94,926 to €73,000

  • Tax, wage and social debts -€18,358

    down €18,358 (-91.0%), from €20,163 to €1,805

Income statement
  • Financial income -€32,154

    down €32,154 (-61.1%), from €52,635 to €20,481

    of which Financial income: -€32,332

  • Gross operating margin +€24,359

    up €24,359 (+11.5%), from €211,642 to €236,001

  • Financial charges -€6,973

    down €6,973 (-61.8%), from €11,275 to €4,302

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €161,192
Gross operating margin +€24,359
Depreciation +€1,097
Other operating charges +€179
Financial income -€32,154
Financial charges +€6,973
Taxes +€1,774
Result 2025 €163,420
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€132,322
Investment -€604,898
Financing -€73,000
Cash 2024 €641,839
Net result for the year +€163,420
Depreciation +€16,374
Smaller working-capital items +€261
Deferred charges and accrued income -€7,448
Tax, wage and social debts -€18,358
Other debts -€21,926
Investment in fixed assets (net) -€8,339
Current investments -€596,560
Contributions, distributions and other -€73,000
Cash 2025 €96,263
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €773,930 €824,333 +€50,403 +6.5%
Fixed assets 21/28 €57,467 €49,432 -€8,035 -14.0%
Tangible fixed assets 22/27 €57,417 €49,382 -€8,035 -14.0%
Plant, machinery and equipment 23 €24,308 €27,405 +€3,097 +12.7%
Furniture and vehicles 24 €33,109 €21,977 -€11,132 -33.6%
Financial fixed assets 28 €50 €50 = 0.0%
Current assets 29/58 €716,464 €774,902 +€58,438 +8.2%
Amounts receivable within one year 40/41 €4,341 €4,346 +€6 +0.1%
Trade receivables 40 €4,341 €0 -€4,341 -100%
Other amounts receivable 41 €0 €4,346 +€4,346
Current investments 50/53 €41,175 €637,735 +€596,560 +1,449%
Cash at bank and in hand 54/58 €641,839 €96,263 -€545,576 -85.0%
Deferred charges and accrued income 490/1 €29,109 €36,557 +€7,448 +25.6%
Total equity and liabilities 10/49 €773,930 €824,333 +€50,403 +6.5%
Equity 10/15 €651,112 €741,532 +€90,420 +13.9%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €633,860 €722,860 +€89,000 +14.0%
Distributable reserves 133 €633,860 €722,860 +€89,000 +14.0%
Profit (loss) carried forward 14 €4,852 €6,272 +€1,420 +29.3%
Amounts payable 17/49 €122,818 €82,801 -€40,017 -32.6%
Amounts payable within one year 42/48 €115,255 €75,238 -€40,017 -34.7%
Trade debts 44 €166 €433 +€267 +160%
Suppliers 440/4 €166 €433 +€267 +160%
Taxes, remuneration and social security 45 €20,163 €1,805 -€18,358 -91.0%
Taxes 450/3 €20,163 €1,805 -€18,358 -91.0%
Other amounts payable 47/48 €94,926 €73,000 -€21,926 -23.1%
Accrued charges and deferred income 492/3 €7,563 €7,563 = 0.0%
Non-recurring operating income 76A €0 - =
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €17,470 €16,374 -€1,097 -6.3%
Other operating charges 640/8 €980 €801 -€179 -18.2%
Gross operating margin 9900 €211,642 €236,001 +€24,359 +11.5%
Operating profit (loss) 9901 €193,191 €218,826 +€25,635 +13.3%
Financial income 75/76B €52,635 €20,481 -€32,154 -61.1%
Recurring financial income 75 €52,635 €20,303 -€32,332 -61.4%
Non-recurring financial income 76B - €178 +€178
Financial charges 65/66B €11,275 €4,302 -€6,973 -61.8%
Recurring financial charges 65 €11,275 €4,302 -€6,973 -61.8%
Profit (loss) for the period before taxes 9903 €234,550 €235,004 +€454 +0.2%
Income taxes 67/77 €73,358 €71,584 -€1,774 -2.4%
Profit (loss) for the period 9904 €161,192 €163,420 +€2,228 +1.4%
Profit (loss) for the period to be appropriated 9905 €161,192 €163,420 +€2,228 +1.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€844,873 to €1.0m

Midpoint €923,891 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €741,532
Capitalised earnings €948,214 to €1.3m
Indication €844,873 to €1.0m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€741,532
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€741,532

Capitalised earnings

net result for the year (9904)
2025
€163,420
excluding non-recurring income and charges
€163,242
2024
€161,192
2023
€78,315
excluding non-recurring income and charges
€73,815
2022
€37,489
2021
€72,454
Average result, excluding non-recurring income and charges
€132,750
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€948,214 / €1.1m / €1.3m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.